Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
NHS England North West
Q83
Manchester
M1 3BN
UK
E-mail: necsu.neprocurement@nhs.net
NUTS: UKD
Internet address(es)
Main address: https://www.england.nhs.uk/north-west/
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
NHSE1051 Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England
Reference number: NHSE1051
II.1.2) Main CPV code
85100000
II.1.3) Type of contract
Services
II.1.4) Short description
Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
1 650 000.00
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UKD
II.2.4) Description of the procurement
Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA)
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award.
The Relevant Authority is intending to award a contract to the existing provider following Direct Award Process C.
The publication of this notice marks the start of the Standstill Period.
Representations by providers must be made to decision makers by 27 March 2026.
This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
The contract will commence on 01 April 2026 and conclude on 31 March 2029.
II.2.5) Award criteria
Quality criterion: The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard
/ Weighting: 100
Cost criterion: The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard
/ Weighting: 100
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation
The Relevant Authority intends to issue a contract via Direct Award Process C.
The Relevant Authority has taken into account the key criteria and applied the basic selection criteria, and is content that the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract
Title: Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England.
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
16/03/2026
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Manchester University Foundation Trust
1049274
Cobbett House, Oxford Road
Manchester
M13 9WL
UK
NUTS: UKD3
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 1 650 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award.
The publication of this notice marks the start of the Standstill Period.
Representations by providers must be made to decision makers by 27 March 2026.
This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
Written representations should be sent to: necsu.neprocurement@nhs.net
The award decision was made on 16 March 2026 by the North West Specialised Commissioning Senior Leaders Team.
The Relevant Authority, as part of the Direct Award C process, have reviewed the key criteria. The evidence shows that the Provider can satisfy the proposed new contract.
The information gathered evidences that the incumbent provider meets the key criteria and gives assurance that they can continue to provide the service within the new contract.
The current Provider is providing a quality service which meets the needs of the population they serve and is continually addressing and reducing inequalities in both service, access and outcomes. It shows the current provider is treating both patients and staff with equality and are continually seeking improvements in social value including their environment.
All involved in the process completed a conflict of interest declaration. No conflicts were identified.
VI.4) Procedures for review
VI.4.1) Review body
NHS England North West
Manchester
UK
VI.5) Date of dispatch of this notice
16/03/2026